542 related articles for article (PubMed ID: 26095331)
1. Retrospective Evaluation of Postoperative Bleeding Events in Patients Receiving Rivaroxaban After Undergoing Total Hip and Total Knee Arthroplasty: Comparison with Clinical Trial Data.
Wood RC; Stewart DW; Slusher L; El-Bazouni H; Cluck D; Freshour J; Odle B
Pharmacotherapy; 2015 Jul; 35(7):663-9. PubMed ID: 26095331
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban or Enoxaparin.
Ricket AL; Stewart DW; Wood RC; Cornett L; Odle B; Cluck D; Freshour J; El-Bazouni H
Ann Pharmacother; 2016 Apr; 50(4):270-5. PubMed ID: 26783354
[TBL] [Abstract][Full Text] [Related]
3. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
4. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.
Anderson DR; Dunbar M; Murnaghan J; Kahn SR; Gross P; Forsythe M; Pelet S; Fisher W; Belzile E; Dolan S; Crowther M; Bohm E; MacDonald SJ; Gofton W; Kim P; Zukor D; Pleasance S; Andreou P; Doucette S; Theriault C; Abianui A; Carrier M; Kovacs MJ; Rodger MA; Coyle D; Wells PS; Vendittoli PA
N Engl J Med; 2018 Feb; 378(8):699-707. PubMed ID: 29466159
[TBL] [Abstract][Full Text] [Related]
5. Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.
Levitan B; Yuan Z; Turpie AG; Friedman RJ; Homering M; Berlin JA; Berkowitz SD; Weinstein RB; DiBattiste PM
Vasc Health Risk Manag; 2014; 10():157-67. PubMed ID: 24707185
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials.
Ning GZ; Kan SL; Chen LX; Shangguan L; Feng SQ; Zhou Y
Sci Rep; 2016 Mar; 6():23726. PubMed ID: 27020475
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis.
Liu J; Zhao J; Yan Y; Su J
Medicine (Baltimore); 2019 Mar; 98(9):e14539. PubMed ID: 30817570
[TBL] [Abstract][Full Text] [Related]
8. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.
Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK
Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
[TBL] [Abstract][Full Text] [Related]
10. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin.
Yen SH; Lin PC; Kuo FC; Wang JW
Biomed J; 2014; 37(4):199-204. PubMed ID: 25116715
[TBL] [Abstract][Full Text] [Related]
11. Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.
Turpie AG; Lassen MR; Eriksson BI; Gent M; Berkowitz SD; Misselwitz F; Bandel TJ; Homering M; Westermeier T; Kakkar AK
Thromb Haemost; 2011 Mar; 105(3):444-53. PubMed ID: 21136019
[TBL] [Abstract][Full Text] [Related]
12. Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.
Duggan ST
Am J Cardiovasc Drugs; 2012 Feb; 12(1):57-72. PubMed ID: 22272729
[TBL] [Abstract][Full Text] [Related]
13. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
Ma G; Zhang R; Wu X; Wang D; Ying K
Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
[TBL] [Abstract][Full Text] [Related]
14. Rivaroxaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis after Hip and Knee Arthroplasty.
Charters MA; Frisch NB; Wessell NM; Dobson C; Les CM; Silverton CD
J Arthroplasty; 2015 Jul; 30(7):1277-80. PubMed ID: 25724111
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
[TBL] [Abstract][Full Text] [Related]
16. Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing.
Sindali K; Rose B; Soueid H; Jeer P; Saran D; Shrivastava R
Eur J Orthop Surg Traumatol; 2013 May; 23(4):481-6. PubMed ID: 23412293
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for Thromboprophylaxis.
Lindquist DE; Stewart DW; Brewster A; Waldroup C; Odle BL; Burchette JE; El-Bazouni H
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1315-1321. PubMed ID: 29716395
[TBL] [Abstract][Full Text] [Related]
18. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.
Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W
Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902
[TBL] [Abstract][Full Text] [Related]
19. The Effect of BMI and Gender on Bleeding Events when Rivaroxaban Is Administered for Thromboprophylaxis Following Total Hip and Total Knee Arthroplasty.
Krauss ES; Cronin M; Dengler N; Simonson BG; Altner K; Daly M; Segal A
Semin Thromb Hemost; 2019 Mar; 45(2):180-186. PubMed ID: 30566970
[TBL] [Abstract][Full Text] [Related]
20. A comparison of complications requiring return to theatre in hip and knee arthroplasty patients taking enoxaparin versus rivaroxaban for thromboprophylaxis.
Chahal GS; Saithna A; Brewster M; Gilbody J; Lever S; Khan WS; Foguet P
Ortop Traumatol Rehabil; 2013; 15(2):125-9. PubMed ID: 23652532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
